Literature DB >> 1530658

Increase in rat brain glutathione following intracerebroventricular administration of gamma-glutamylcysteine.

E Pileblad1, T Magnusson.   

Abstract

The effects of intracerebroventricularly (i.c.v.) administered gamma-glutamylcysteine (gamma-GC) and glutathione (GSH) monoethyl ester, subcutaneously (s.c.) injected L-2-oxo-4-thiazolidinecarboxylic acid (OTC) and intraperitoneally (i.p.) administered cysteine on the concentration of GSH in rat brain were investigated. The brain content of GSH, cysteine and gamma-GC was determined by HPLC with electrochemical detection (gold/mercury electrode) using N-acetylcysteine as internal standard. A dose-dependent increase in the GSH concentration (145-170% of controls) was found in the substantia nigra (SN) and in the rest of the brain stem after injection of gamma-GC, whereas no significant alterations in GSH were observed in the striatum and in the cerebral cortex. High levels of gamma-GC could be detected in the brain tissue after the administration, and the concentration of cysteine did also increase markedly after gamma-GC injection in all brain regions assessed. I.c.v. administration of L-buthionine sulfoximine (L-BSO) reduced the brain concentration of GSH by 50-70% within 24 hr. Injection of gamma-GC 24 hr after L-BSO resulted in an increase in GSH up to control values within 1-3 hr in the SN and the rest of the brain stem, whereas only a slight increase in GSH was observed in the striatum and the cerebral cortex. The concentration of GSH in the striatum and SN did not change after i.p. injection of cysteine, but a slight increase in the GSH concentration in the limbic region was observed. GSH monoethyl ester (i.c.v.) and OTC (s.c.) did not produce any significant increase in the GSH concentration in the brain. When the GSH concentration had been reduced by administration of L-BSO (i.c.v.; 24 hr) subsequent injection of GSH monoethyl ester led to a slight increase in the striatal and limbic GSH levels. These data show that, of the drugs studied, gamma-GC was the most effective in increasing brain GSH. It could thus serve as a valuable tool in future studies regarding metabolism and function of GSH in the brain. The observed difference in the effects of gamma-GC in different brain regions indicate that the brain tissue is not homogeneous with regard to GSH synthesizing capacity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530658     DOI: 10.1016/0006-2952(92)90121-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione.

Authors:  R Dringen; B Pfeiffer; B Hamprecht
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

2.  Non-invasive monitoring of L-2-oxothiazolidine-4-carboxylate metabolism in the rat brain by in vivo 13C magnetic resonance spectroscopy.

Authors:  Michael P Gamcsik; M Daniel Clark; Susan M Ludeman; James B Springer; Michael A D'Alessandro; Nicholas E Simpson; Roxana Pourdeyhimi; C Bryce Johnson; Stephanie D Teeter; Stephen J Blackband; Peter E Thelwall
Journal:  Neurochem Res       Date:  2010-12-15       Impact factor: 3.996

3.  Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine.

Authors:  Aric Madayag; Doug Lobner; Kristen S Kau; John R Mantsch; Omer Abdulhameed; Matthew Hearing; Mark D Grier; David A Baker
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

4.  Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.

Authors:  David A Baker; Aric Madayag; Lars V Kristiansen; James H Meador-Woodruff; Vahram Haroutunian; Ilangovan Raju
Journal:  Neuropsychopharmacology       Date:  2007-08-29       Impact factor: 7.853

5.  Potential of a γ-glutamyl-transpeptidase-stable glutathione analogue against amyloid-β toxicity.

Authors:  Swati S More; Robert Vince
Journal:  ACS Chem Neurosci       Date:  2012-01-03       Impact factor: 4.418

6.  Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain.

Authors:  T A Seaton; P Jenner; C D Marsden
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 7.  Prodrug approach for increasing cellular glutathione levels.

Authors:  Ivana Cacciatore; Catia Cornacchia; Francesco Pinnen; Adriano Mollica; Antonio Di Stefano
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

8.  The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes.

Authors:  Nady Braidy; Martin Zarka; Bat-Erdene Jugder; Jeffrey Welch; Tharusha Jayasena; Daniel K Y Chan; Perminder Sachdev; Wallace Bridge
Journal:  Front Aging Neurosci       Date:  2019-08-08       Impact factor: 5.750

9.  Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats.

Authors:  Magdalena Górny; Agnieszka Wnuk; Adrianna Kamińska; Kinga Kamińska; Grażyna Chwatko; Anna Bilska-Wilkosz; Małgorzata Iciek; Małgorzata Kajta; Zofia Rogóż; Elżbieta Lorenc-Koci
Journal:  Molecules       Date:  2019-11-22       Impact factor: 4.411

10.  Nutritional regulation of glutathione in stroke.

Authors:  P G Paterson; B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.